In March 2024, prices for drugs not related to VED increased by an average of 1.1%, and for drugs included in it – by 0.9%. This information is contained in the Rosstat report on the consumer price index in the previous month.
Among the drugs not included in the Vital and Essential Drugs list, prices have increased:
– fluocinolone acetonide (+2.5%);
– Corvalol and sulfacetamide (+2.4%);
– canephron N (+2.3%);
– troxerutin (+2.1%);
– levomekol (+1.7%);
– ketorol express (+1.6%);
– almagel (+1.5%);
– allochol and naphazoline (+1.4%);
– nimesulide (+1.3%);
– afobazole and enterosgel (+1.2%), etc.
Among the drugs included in the Vital and Essential Drugs list, bisacodyl has increased in price most significantly (+11.5%).
In addition to this, the price has increased for:
– drotaverine (“No-shpa”, +2.3%);
– acetylcysteine (“ACC”, +1.4%);
– enalapril and ceftriaxone (+1.3%);
– glycine, hydrogen peroxide and furosemide (+1.0%).
Some medical products have also become more expensive, including:
– disposable syringes (+1.2%);
– bandages (+0.9%);
– cotton wool (+0.8%).
